StromaBio is a clinical stage biopharma company developing Mesenchymal Stromal Cell (MSC) based cell therapies. Founded on more than two decades of world leading research, its aim is to bring new advanced therapies to patients with Respiratory Distress Syndrome (ARDS), and neurodegenerative Alzheimer’s Disease (AD)